In the high court of South Africa, case no. 4138/98: The global politics of access to low-cost AIDS drugs in poor countries

David Barnard

Research output: Contribution to journalArticle

40 Scopus citations

Abstract

In 1998, 39 pharmaceutical manufacturers sued the government of South Africa to prevent the implementation of a law designed to facilitate access to AIDS drugs at low cost. The companies accused South Africa, the country with the largest population of individuals living with HIV/AIDS in the world, of circumventing patent protections guaranteed by intellectual property rules that were included in the latest round of world trade agreements. The pharmaceutical companies dropped their lawsuit in the spring of 2001 after an avalanche of negative publicity. Yet, despite the government's victory, AIDS drugs remain very expensive in South Africa, and the government still refuses to provide antiretroviral therapy to adults. These events have shone a spotlight, not only on the possibilities for coordinated political activism in the era of instant global communications, but also on the tangled social, economic, and political dimensions of AIDS treatment in poor countries.

Original languageEnglish (US)
Pages (from-to)159-174
Number of pages16
JournalKennedy Institute of Ethics Journal
Volume12
Issue number2
DOIs
StatePublished - Jun 2002

ASJC Scopus subject areas

  • Issues, ethics and legal aspects
  • Health(social science)
  • Health Policy
  • History and Philosophy of Science

Fingerprint Dive into the research topics of 'In the high court of South Africa, case no. 4138/98: The global politics of access to low-cost AIDS drugs in poor countries'. Together they form a unique fingerprint.

  • Cite this